Nutra Pharma NPHC undervalued phase - NPHC Nutra Pharma Corp.

(Total Views: 782)

Posted On: 11/12/2017 3:47:37 PM

Post# of 102

Posted By: mac

Re: mac #42

Nutra Pharma NPHC undervalued phase II news will send it. No R/S

400,000 debt reduced
http://www.otcmarkets.com/edgar/GetFilingHtml...D=12359349

Quote:
Email from Rik (Great things on the horizon)
CEO UPDATE: NPHC

We need to file our 10Q next week. After that, we can announce our ‘go-forward’

plans for the company. This includes: the ongoing infomercial campaign for Pet

Pain-Away; the marketing of Nyloxin; the retail rollout for Nyloxin; the ongoing

efforts to get our products into the VA and government buyers; our efforts in

International registrations for our products; and our efforts in moving RPI-78M

into clinical trials for Pediatric Multiple Sclerosis under our Orphan Designation.

We are working with finance partners and potential joint venture partners to bring

in from $2M to $20M in furtherance of the business plan. We expect to make

announcements later this month to update our shareholders.

Thank you for your interest in Nutra Pharma,

Rik

Post from 'tink/hub'